| Compound Information | |
|---|---|
| ID | 140 |
| TrivialName | Ginsenoside F1 |
| Type | PPT |
| MF | C₃₆H₆₂O₉ |
| MolecularWeight | 638.883 |
| IUPACName | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol |
| m/z | 683.4374 |
| Retention Time | 26.53 |
| CCS | 271.63 |
| Adducts | [M−H+HCOOH]− |
| Isomeric SMILES | CC1(C)[C@@H](O[H])CC[C@@]2(C)C1[C@@H](O[H])C[C@]3(C)C2C[C@@H](O)C4[C@@]3(C)CCC4[C@@](C)(O[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O5)CC/C=C(C)/C |
| Canonical SMILES | CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(O)CC12C |
| Source | PG |
| Functions | apoptosis inhibitor, Anti-tumor(GJIC modulators), hemostatic, anti-diabetic, anti-obesity |
| Year | 1976 |
| References | |
| Structure |
|